What FDA Establishment Registration Actually Requires

A device company can go years treating FDA establishment registration and device listing as paperwork a contractor files once and forgets. It is not that. Registration and listing are separate, ongoing legal obligations with their own statute, their own annual deadline, and their own enforcement provision — entirely apart from whatever 510(k), De Novo, or PMA pathway the device itself is going through. Confusing the two, or assuming either one means FDA signed off on anything, is the single most common way this requirement goes wrong.

In brief

Registration (21 CFR § 807.20) is establishment-level: every domestic and foreign manufacturer, contract manufacturer, specification developer, repackager, relabeler, and initial importer of a device must register. Listing is device-level: each device the establishment handles gets its own listing record.
Both are filed electronically through FDA’s registration and listing system (21 CFR § 807.21), and both must be renewed every year in a fixed window FDA opens from October 1 through December 31, set by FDCA § 510(p) (21 U.S.C. § 360(p)).
A device made in an establishment that is not duly registered, or not included in the required listing, is misbranded under FDCA § 502(o) (21 U.S.C. § 352(o)) — a provision FDA cites directly in warning letters against firms with no current-year registration on file.
Registering an establishment or listing a device does not mean FDA approved, cleared, or endorsed anything. 21 CFR § 807.39 makes a claim that implies otherwise a form of misbranding in its own right.

Two obligations, not one

Registration attaches to the business, not the product: if your firm manufactures, prepares, propagates, compounds, processes, repackages, relabels, or is the initial U.S. importer of a device, you register as an establishment under 21 CFR § 807.20, regardless of whether any device you handle has cleared review yet. Listing attaches to the product: once registered, the establishment lists every device it makes or distributes, and each device gets its own listing record inside FDA’s registration and listing database — the same public record that eventually carries the device’s UDI and GUDID information once that device reaches market. New entrants routinely get the sequencing backwards, waiting for a 510(k) to clear before registering, or assuming an early-stage device with no clearance yet has nothing to list. Neither is true. Registration and listing run on their own clock, independent of wherever the premarket review itself stands, and the clock starts as soon as the establishment begins the activity that triggers registration — not when the device is finally cleared to ship.

Why the October–December window has teeth

FDCA § 510 (21 U.S.C. § 360) is the statutory basis for annual registration, and § 510(p) (21 U.S.C. § 360(p)) is specific about when: every registered establishment refiles electronically each year in a window FDA opens October 1 and closes December 31, covering the fiscal year that follows. There is no quiet grace period built into that window closing. A device manufactured in an establishment that is not currently, properly registered — whether it never registered at all or simply let a prior registration lapse past the renewal window — is misbranded under FDCA § 502(o) if it also was not included in the required listing. That is not a hypothetical: FDA has used exactly this provision in waves of warning letters against firms it has no current fiscal-year registration or listing on file for, warning that the device is misbranded and that enforcement can include seizure and injunction. The violation sits on the establishment and the listing record, not on the device’s underlying safety or quality — which is precisely what makes it easy to miss. A device can be well made and still be legally misbranded because the paperwork behind it lapsed in December.

Where this goes wrong

Treating a registration number as a credential

21 CFR § 807.39 exists because companies keep trying to market an FDA establishment registration number as though it signals agency approval or endorsement. It signals neither. FDA has cited this provision directly in warning letters over marketing language that implies otherwise.

Waiting for clearance before registering or listing

Registration and listing are administrative obligations tied to the act of manufacturing or importing, not to where a 510(k), De Novo, or PMA stands. A device can be — and often should be — listed well before its premarket pathway resolves.

Letting a prior-year registration lapse

A missed October–December renewal is not a paperwork delay to clean up later. Under § 502(o), it puts every device made at that establishment in the same misbranded position as a device from an establishment that never registered at all.

Registration and listing are worth checking on their own timeline, separate from whatever else is happening with a device’s premarket file — the same database that carries a device’s listing record is also where its UDI record eventually lives, so the two are worth reading together once a device is on market.

Sources & further reading

eCFR — 21 CFR § 807.20, Who must register and submit a device list? ecfr.gov
eCFR — 21 CFR § 807.21, How to register establishments and list devices ecfr.gov
Cornell LII — 21 CFR § 807.39, Misbranding by reference to establishment registration or to registration number law.cornell.edu
Cornell LII — 21 U.S.C. § 360, Registration of producers of devices (FDCA § 510, including the § 510(p) annual filing window) law.cornell.edu
Cornell LII — 21 U.S.C. § 352(o), Misbranded drugs and devices (FDCA § 502(o)) law.cornell.edu
FDA — Device Registration and Listing fda.gov
Regulatory Academy — The 510(k) Review, From Submission to the SE Letter regulatoryacademy.com
Regulatory Academy — How to Read a UDI Record regulatoryacademy.com

This essay is provided for general educational purposes and reflects the regulatory landscape as of its publication date. It is not legal, regulatory, or career advice.